Exchange: NASDAQ·Updated 06:58 PM EDT
MNKD logo

MNKD Mannkind Corp

$3.34
$0.01
(0.30%)
Today
Closed $3.34
$0.00
(0.00%)
After Hours
EarningsNov 4
Mkt Cap$1.08B
Vol2.38M

About MNKD

MannKind Corporation (Nasdaq: MNKD) is a commercial-stage biopharmaceutical company with a diversified business spanning marketed products, strategic collaborations and a proprietary development pipeline. Focused on cardiometabolic and orphan lung diseases, MannKind’s portfolio includes Afrezza® (inhaled mealtime insulin), FUROSCIX® (furosemide injection for fluid overload) and V-Go® (all-in-one insulin delivery patch). Its proprietary Technosphere® technology is also utilized in Tyvaso DPI® (an inhaled treatment for pulmonary hypertension), marketed by United Therapeutics. The company is advancing additional inhaled therapies and drug-device combination products designed to address serious unmet medical needs. Founded by Alfred E. Mann in 1991, MannKind is headquartered in Danbury, Connecticut.
56

Bullish Sentiment

How do you feel about MNKD?

sla55
$MNKD Short Interest 09/15/26: 29,398,550 (SP: $3.56) Days to cover: 9.078325 Short Interest 08/31/26: 26,554,857 (SP: $4.01) Change: 2,843,693
1
21
Eriiclapton52
$MNKD Will never understand a public company so translucent. Making no marketing information available to the most important sector of a publicly held company sit in the dark waiting for just a crumb of how sales are going to give us some hope. I don't think that's too much to ask for. How ready was marketing to take the baton just prior to approval of Affrezza for KIDS? Just can't understand what's so hard keeping us informed.
12
Serghei
$MNKD Keep stop-losses lower and accumulate! Clinical risks are gone; monetization is here. Whales manipulate the price with surgical precision to shake out retail. Mark my words in 2-3 quarters (if a buyout doesn't happen first): MNKD will cross $9, leaving retail empty-handed. The reality: Real monetization starts for the FDA pipeline. By Q1 2027, inhaled insulin disrupts India via Cipla—a massive market where expensive pumps fail and syringes pose bio-hazards. By late 2026, insurance contracts will roll in. Furoscix cuts hospital costs, securing quick coverage. Plus, their weight-loss entry threatens Big Pharma, making MNKD cheap pocket change for a buyout. Retail float will dry up before the explosion.
2
14
Serghei
$MNKD Here is exactly what I’ve been warning you about these past few days... 🧐 It was obvious they were going to attack the support when the volume was low! Classic whale game: they artificially pushed the price down just to trigger your stop-losses and steal your cheap shares. The stop-losses sitting right under the $3.20 support light up on their screens and are seen like a New Year's Christmas tree! Typical institutional accumulation phase! Just look at that massive +1.5M volume spike and the OBV exploding vertically. They swallowed everything! The manipulation will continue until the institutions shake you out of your cheap shares, or until the next positive news drop when they will completely lose control of the price and it flies! Don't play their game, hold strong! 💎🙌 #MNKD #Bullish #Whales #MarketManipulation #BioTech
1
15
TaylorStSauvage
$MNKD Mid day Champagne Cheers 🥂 2 all Mannkinders... here's hoping Nate's not wrong about UTHR... We're worth $30+ a share but, after 15 years, I'll take $20 and run away like my pantaloons were on fire! 🔥 If not United, may some other player swoop in for the steal of the century
19
NatesNotes
$MNKD Tomorrow could change everything, but, at least at the moment, it looks like today was a day that should make all longs even more excited and optimistic than we were yesterday, eh? Here's to more gains in the months and years ahead! Cheers! ;-) #knowwhatyouown #factsmatter
19
kevinmik
$MNKD 2026 is winding down with MNKD stock price down 42% year-to-date. Hard to believe where the stock price sits today @ $3.34 vs where it opened the year @ $5.73, down 42%, instead of what I and what I expect most longs were hoping to see in late 2026, with the stock price sitting at $8.13 up 42% year-to-date. Despite the stock price suffering a huge loss so far in 2026, management will still be rewarded with a huge payout approved by MNKD Board of Directors for having achieved catalysts and goals established to be met in the 1H 2026, which they did. So despite the stock price being down 42% it will not have the same impact on management vs the huge impact its having on shareholders with management still walking away with huge compensation awards handed to them and their selling previously issued free stock options/rsu. If the stock price doesn't turn around in the 4Q 2026, someone at MNKD needs to be held accountable for it and held accountable to MNKD Shareholders.
13
Serghei
$MNKD During the next market opens, expect a direct attack on the support zone to flush out the remaining stop-losses once again. Institutional whales are running out of time to accumulate shares, so they are going to use highly aggressive strategies to shake the shares right out of you.They need that cheap liquidity before the next big catalyst drops. Bookmark this message. In a short while, you will look back and realize I was exactly right. Hold your ground and stop feeding their algorithms.
17
kevinmik
$MNKD Just listened to United Therapeutic presentation at the Bernstein Conference held yesterday and Martine said drug launches will start with #1 & 2 for Nebulize Tyvaso for IPF and PPF and then #3 and #4 for Tyvaso DPI for IPF and PPF. She said Tyvaso DPI is already approved and the #1 product prescribed in PH-ILD. Martine added following launches #1, 2, 3 & 4 United plans to launches #5, 6 & 7 for softmist Trezmi, for ILD, IPF, PPF. Martine was asked which program does she believe in most important and said Ralinepag which she believes will be their top product. MNKD currently working on Ralinepag DPI for PAH, PH-ILD, IPF & PPF. My take away Technosphere DPI will play a critical role in the future growth of United Therapeutic that Martine expects could reach $100 billion in revenues and MNKD will benefit greatly from it either is significant royalties they will receive or if they choose, sell Tyvaso DPI and Ralinepag DPI rights to United Therapeutic in a huge billion dollar deal
16
Kuka
$MNKD just a reminder... no matter what anyone says on this message board.... institutional ownership is currently 70% to 80%. Based on artificial intelligence analyzing everything. The bashers don't want you to know this and they will say it's wrong. Its right.
9
laborer75
$MNKD I wonder how many automated sell orders were executed today with folks not paying attention? With aggressive buying following those stops taken out, who wanted those shares? I doubt retail was the reason the stock traded at nearly five times its recent daily average. 👍
15
Pickin
$MNKD it’s cringe worthy to watch movies where they rip on some over paid executive making $3,000,000 yet Mannkind is paying a rookie CEO $10,000,000 to provide zero return for shareholders year after year. He’s either got blackmail photos of someone or he’s just the luckiest pill counter that ever lived. I do realize the inept board set the bar pretty darn low at topping Matt Pfeiffer for the job. Please 🙏 can we get a real CEO.
10
laborer75
$MNKD OK. I've done enough 'poking the bears'. 🤣 It's all in good fun. Hope everyone has a great rest of the afternoon and evening. 👍
14
laborer75
$MNKD The private placement is the culprit behind the recent volume spike and downward pressure. It triggered stops and in turn, increased short numbers. The great news is Mannkind has over a 2 year cash runway. Increased sales and revenue will add to that. Being so oversold with an increase in shorting, it's gonna attract a lot of folks if they put out a decent Q3. And it could happen...... we'll see.
13
Kool_Aid_Mann
$MNKD Fire the CEO, cancel his variable compensation. Clear out the rest of the dead-wood and saboteurs. #SaveMannkind
9
Kuka
$MNKD I admit I am a novice investor but I think this is probably one of the worst cases of a stock being manipulated over an extended period of time in history. I don't know how to quantify it or prove it but if anyone has seen another stock get beaten up like this for 14 years let me know
1
10
Catalystinvestor
$MNKD not happy with the stock price action but couldn’t help but add more to my overflowing long position as this price is too cheap to ignore
12
Spottswoode
$MNKD pretty much straight down since GLP announcement and investor conferences. Votes are in: get an IDN strategy (not just hope), and slow roll GLP. What else?! Oh yeah we need TreT sales to start going back up.
1
9
Kool_Aid_Mann
$MNKD Well, here's to another 5 years of bagholding just to get back to where we were a year ago. Costly mistake after costly mistake. Either sell it all to $UTHR or fire the MNKD CEO. Either way we gap up overnight.
8
Jorder61
$MNKD while I realize the scripts numbers are pathetic relative to what they could be if we had a good ceo …..Afrezza breached 900 total scripts last week. Assuming that’s correct we might have an upward trend
1
3

Advertisement|Remove ads.